The efficacy and safety of olokizumab for rheumatoid arthritis: a systematic review, pairwise, and network meta-analysis

Olokizumab (OKZ) is a novel IL-6 inhibitor that directly targets IL-6 rather than its receptor. We aim to evaluate the efficacy and safety of OKZ for patients with rheumatoid arthritis (RA) and to investigate the optimal treatment regimen. A systematic review, pairwise, and network meta-analysis syn...

Descripción completa

Detalles Bibliográficos
Autores principales: Abuelazm, Mohamed, Ghanem, Ahmed, Mahmoud, Abdelrahman, Brakat, Aml M., Elzeftawy, Mohamad A., Mamdouh Fayoud, Aya, Awad, Ahmed K., Abdelazeem, Basel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202974/
https://www.ncbi.nlm.nih.gov/pubmed/36792848
http://dx.doi.org/10.1007/s10067-023-06519-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202974/
https://www.ncbi.nlm.nih.gov/pubmed/36792848
http://dx.doi.org/10.1007/s10067-023-06519-6

Ejemplares similares